SCHEMBL11060770

SCHEMBL11060770

O=C1C[C@H](O)C[C@@H](c2ccccc2)O1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.45
HSD17B10 Q99714 2/20 0.45
AR P10275 2/20 0.45
MAOB P27338 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
CYP1A1 P04798 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP1B1 Q16678 1/20 0.43
MEN1 O00255 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
MAPT P10636 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
KMT2A Q03164 1/20 0.43
MAOA P21397 1/20 0.42
PSMB5 P28074 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11060773 1.00 CYP19A1 (0.45) CYP19A1HSD17B10ARMAOBKDM4E
SCHEMBL4260040 0.78 MAOB (0.60) CYP19A1HSD17B10ARMAOBKDM4E
SCHEMBL27018775 0.74 CYP19A1 (0.46) CYP19A1HSD17B10ARMAOBKDM4E
SCHEMBL27018784 0.74 CYP19A1 (0.46) CYP19A1HSD17B10ARMAOBKDM4E
SCHEMBL27779717 0.74 CYP19A1 (0.46) CYP19A1HSD17B10ARMAOBKDM4E
SCHEMBL5349568 0.74 CYP19A1 (0.46) CYP19A1HSD17B10ARMAOBKDM4E
SCHEMBL5037122 0.72 TSHR (0.50) CYP19A1HSD17B10ARMAOBKDM4E
SCHEMBL9050259 0.71 CTRB1 (0.45) CYP19A1HSD17B10ARMAOBKDM4E
SCHEMBL3816926 0.70 MAOB (0.47) CYP19A1HSD17B10ARMAOBKDM4E
SCHEMBL9711662 0.70 MAOB (0.56) CYP19A1HSD17B10ARMAOBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0010299-B1 PHARMACEUTICAL COMPOSITION USEFUL FOR THE TREATMENT OF HYPERCHOLESTEREMIA MERCK & CO. INC. (US) 1984-02-15 EP disclosed
EP-0010299-A1 Pharmaceutical composition useful for the treatment of hypercholesteremia MERCK & CO. INC. (US) 1980-04-30 EP disclosed
EP-0010299-A1 Pharmaceutical composition useful for the treatment of hypercholesteremia MERCK & CO. INC. (US) 1980-04-30 EP disclosed